Market Overview:
The global platelet aggregation devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, rising geriatric population, and technological advancements in platelet aggregation devices. Based on type, the global platelet aggregation devices market is segmented into systems, reagents & consumables, and accessories. The systems segment is further sub-segmented into light transmission aggregometry (LTA) systems and impedance aggregometry (IA) systems. The LTA systems segment is expected to account for the largest share of the global platelet aggregation devices market in 2018 owing to its high usage rates across hospitals, research and academic institutes, diagnostic laboratories, and blood banks. Based on application, the global platelet aggregation devices market is divided into hospitals & clinics; research & academic institutes; diagnostic laboratories; blood banks; and other applications such as veterinary clinics & pet shops).
Product Definition:
A platelet aggregation device is a medical device used to measure the rate of platelet aggregation in blood. Platelets are important for the clotting process, and devices that measure their aggregation can help doctors diagnose and treat various conditions.
Systems:
Platelet aggregation is the process by which platelets plug into a wound site and form a protective covering over the site. The primary function of platelets is to initiate the inflammatory response in response to injury or trauma. They also have an important role in hemostasis, that is, they help regulate bleeding by forming aoplatelet plug at wound sites and sealing them off from external environment.
Reagents:
Reagents are chemicals that help in enhancing, detecting or modifying a particular property of a biological system. Reagents play an important role in the development of platelet aggregation devices. They are used for various purposes such as detection and quantification, modification and control of certain properties, standardization & controls among others.
Application Insights:
Based on the application, the global platelet aggregation devices market is segmented into hospitals, research and academic institutes, diagnostic laboratories, blood banks and others. Hospitals held the largest share in 2017 owing to increasing prevalence of cardiovascular diseases that require platelet transfusion for treatment. Moreover, rising number of surgeries that require multiple transfusions also contributes to hospital segmentation. Research and academic institutes are anticipated to witness lucrative CAGR over the forecast period due to growing R&D activities pertaining to new drug development for various conditions including cardiovascular diseases. Platelet rich plasma (PRP) injections have been used in recent years as a potential alternative therapy for several conditions such as osteoarthritis pain & arthritis without any adverse effects compared with current available therapies which has driven its demand among research facilities globally.
The other application segment includes clinics/pharmacies/surgeons offices etc.
Regional Analysis:
North America platelet aggregation devices market is majorly dominated by the U.S., which accounted for over 80% of the overall revenue in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some factors attributing to its large share. Moreover, increasing cases of cardiovascular diseases and rising geriatric population prone to cardiac disorders are also expected to drive regional growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to a rise in healthcare expenditure along with growing awareness about platelet rich plasma (PRP) therapy among patients suffering from various orthopedic injuries as well as sports injuries resulting in an increase in demand for aggregration systems used across this region.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in platelet aggregation devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Platelet Aggregation Devices Market Research Report
By Type
Systems, Reagents, Consumables, Accessories
By Application
Hospitals, Research And Academic Institutes, Diagnostic Laboratories, Blood Banks
By Companies
Siemens, Helena Laboratories, Haemonetics, Accriva Diagnostics, F. Hoffman-la Roche, Sysmex, Aggredyne, Tem, Sentinel Ch.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Platelet Aggregation Devices Market Report Segments:
The global Platelet Aggregation Devices market is segmented on the basis of:
Types
Systems, Reagents, Consumables, Accessories
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research And Academic Institutes, Diagnostic Laboratories, Blood Banks
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- Helena Laboratories
- Haemonetics
- Accriva Diagnostics
- F. Hoffman-la Roche
- Sysmex
- Aggredyne
- Tem
- Sentinel Ch.
Highlights of The Platelet Aggregation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Systems
- Reagents
- Consumables
- Accessories
- By Application:
- Hospitals
- Research And Academic Institutes
- Diagnostic Laboratories
- Blood Banks
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Platelet Aggregation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A platelet aggregation devices (PAD) is a medical device that helps to prevent blood clots from forming in the veins. Platelets are small cells that help to form blood clots. PADs work by releasing small amounts of a substance called prostaglandin which causes the platelets to stick together and form a clot.
Some of the key players operating in the platelet aggregation devices market are Siemens, Helena Laboratories, Haemonetics, Accriva Diagnostics, F. Hoffman-la Roche, Sysmex, Aggredyne, Tem, Sentinel Ch..
The platelet aggregation devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Platelet Aggregation Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Platelet Aggregation Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Platelet Aggregation Devices Market - Supply Chain
4.5. Global Platelet Aggregation Devices Market Forecast
4.5.1. Platelet Aggregation Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Platelet Aggregation Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Platelet Aggregation Devices Market Absolute $ Opportunity
5. Global Platelet Aggregation Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Platelet Aggregation Devices Market Size and Volume Forecast by Type
5.3.1. Systems
5.3.2. Reagents
5.3.3. Consumables
5.3.4. Accessories
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Platelet Aggregation Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Platelet Aggregation Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Research And Academic Institutes
6.3.3. Diagnostic Laboratories
6.3.4. Blood Banks
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Platelet Aggregation Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Platelet Aggregation Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Platelet Aggregation Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Platelet Aggregation Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Platelet Aggregation Devices Demand Share Forecast, 2019-2026
9. North America Platelet Aggregation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Platelet Aggregation Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Platelet Aggregation Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Research And Academic Institutes
9.4.3. Diagnostic Laboratories
9.4.4. Blood Banks
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Platelet Aggregation Devices Market Size and Volume Forecast by Type
9.7.1. Systems
9.7.2. Reagents
9.7.3. Consumables
9.7.4. Accessories
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Platelet Aggregation Devices Demand Share Forecast, 2019-2026
10. Latin America Platelet Aggregation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Platelet Aggregation Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Platelet Aggregation Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Research And Academic Institutes
10.4.3. Diagnostic Laboratories
10.4.4. Blood Banks
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Platelet Aggregation Devices Market Size and Volume Forecast by Type
10.7.1. Systems
10.7.2. Reagents
10.7.3. Consumables
10.7.4. Accessories
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Platelet Aggregation Devices Demand Share Forecast, 2019-2026
11. Europe Platelet Aggregation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Platelet Aggregation Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Platelet Aggregation Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Research And Academic Institutes
11.4.3. Diagnostic Laboratories
11.4.4. Blood Banks
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Platelet Aggregation Devices Market Size and Volume Forecast by Type
11.7.1. Systems
11.7.2. Reagens
11.7.3. Consumables
11.7.4. Accessories
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Platelet Aggregation Devices Demand Share, 2019-2026
12. Asia Pacific Platelet Aggregation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Platelet Aggregation Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Platelet Aggregation Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Research And Academic Institutes
12.4.3. Diagnostic Laboratories
12.4.4. Blood Banks
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Platelet Aggregation Devices Market Size and Volume Forecast by Type
12.7.1. Systems
12.7.2. Reagents
12.7.3. Consumables
12.7.4. Accessories
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Platelet Aggregation Devices Demand Share, 2019-2026
13. Middle East & Africa Platelet Aggregation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Platelet Aggregation Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Platelet Aggregation Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Research And Academic Institutes
13.4.3. Diagnostic Laboratories
13.4.4. Blood Banks
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Platelet Aggregation Devices Market Size and Volume Forecast by Type
13.7.1. Systems
13.7.2. Reagents
13.7.3. Consumables
13.7.4. Accessories
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Platelet Aggregation Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Platelet Aggregation Devices Market: Market Share Analysis
14.2. Platelet Aggregation Devices Distributors and Customers
14.3. Platelet Aggregation Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siemens
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Helena Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Haemonetics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Accriva Diagnostics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. F. Hoffman-la Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sysmex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aggredyne
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Tem
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sentinel Ch.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook